Genetic biomarkers in the VEGF pathway predicting response to anti-VEGF therapy in age-related macular degeneration

OBJECTIVE: Age-related macular degeneration (ARMD) is a leading cause of visual impairment. Intravitreal injections of anti-vascular endothelial growth factor (VEGF) are the standard treatment for wet ARMD. There is however, variability in patient responses, suggesting patient-specific factors influ...

Descripción completa

Detalles Bibliográficos
Autores principales: Balikova, Irina, Postelmans, Laurence, Pasteels, Brigitte, Coquelet, Pascale, Catherine, Janet, Efendic, Azra, Hosoda, Yoshikatsu, Miyake, Masahiro, Yamashiro, Kenji, Thienpont, Bernard, Lambrechts, Diether
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936450/
https://www.ncbi.nlm.nih.gov/pubmed/31909188
http://dx.doi.org/10.1136/bmjophth-2019-000273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936450/
https://www.ncbi.nlm.nih.gov/pubmed/31909188
http://dx.doi.org/10.1136/bmjophth-2019-000273

Ejemplares similares